NuCana plc - American Depositary Share (NCNA) News

NuCana plc - American Depositary Share (NCNA): $1.81

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NCNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 391

in industry

Filter NCNA News Items

NCNA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NCNA News Highlights

  • NCNA's 30 day story count now stands at 2.
  • Over the past 21 days, the trend for NCNA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest NCNA News From Around the Web

Below are the latest news stories about NuCana plc that investors may wish to consider to help them evaluate NCNA as an investment opportunity.

NuCana Announces Enrollment of Required Number of Patients to Conduct Second Interim Analysis in the Phase III Biliary Tract Cancer Study

Enrollment of 644 Evaluable Patients Expected to Enable Second Interim Analysis in the Second Half of 2022 First Interim Analysis of 418 Evaluable Patients Remains on Track for the First Half of 2022 Data from Either Interim Analysis May Support an NDA Submission in the United States under the FDA’s Accelerated Approval Program EDINBURGH, United Kingdom, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced it has completed enrollment of the number of patients in the ongoing Phas

Yahoo | February 22, 2022

What You Need To Know About NuCana plc's (NASDAQ:NCNA) Investor Composition

If you want to know who really controls NuCana plc ( NASDAQ:NCNA ), then you'll have to look at the makeup of its share...

Yahoo | February 1, 2022

Is NuCana PLC Sponsored ADR (NCNA) Outperforming Other Medical Stocks This Year?

Here is how NuCana PLC Sponsored ADR (NCNA) and OptiNose (OPTN) have performed compared to their sector so far this year.

Yahoo | January 24, 2022

Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...

Cambridge, MA, based Investment company Opaleye Management Inc. (Current Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus NV, sells ESSA Pharma Inc, Seres Therapeutics Inc, CM Life Sciences Inc, Lumos Pharma Inc, Kezar Life Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Opaleye Management Inc..

Yahoo | December 28, 2021

-$0.25 EPS Expected for NuCana plc (NASDAQ:NCNA) This Quarter

Analysts expect that NuCana plc (NASDAQ:NCNA) will post ($0.25) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for NuCanas earnings, with estimates ranging from ($0.29) to ($0.17). NuCana reported earnings per share of ($0.32) during the same quarter last year, which suggests a positive year over []

Dakota Financial News | December 21, 2021

39,332 Shares in NuCana plc (NASDAQ:NCNA) Acquired by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. bought a new position in shares of NuCana plc (NASDAQ:NCNA) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 39,332 shares of the companys stock, valued at approximately $109,000. Goldman Sachs Group Inc. owned 0.08% of NuCana at the end [] The post 39,332 Shares in NuCana plc (NASDAQ:NCNA) Acquired by Goldman Sachs Group Inc. appeared first on ETF Daily News .

ETF Daily News | December 13, 2021

Here Is A Bargain Stock You Should Look At : NuCana plc (NCNA)

NuCana plc (NASDAQ:NCNA) has a beta value of 0.73 and has seen 0.73 million shares traded in the recent trading session. The company, currently valued at $140.64M, closed the recent trade at $2.75 per share which meant it lost -$0.04 on the day or -1.56% during that session. The NCNA stock price is -184.73% off Here Is A Bargain Stock You Should Look At : NuCana plc (NCNA) Read More »

Marketing Sentinel | November 30, 2021

NuCana plc (NASDAQ:NCNA) Expected to Announce Earnings of -$0.25 Per Share

Brokerages predict that NuCana plc (NASDAQ:NCNA) will announce ($0.25) earnings per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for NuCanas earnings. The highest EPS estimate is ($0.17) and the lowest is ($0.29). NuCana reported earnings of ($0.32) per share in the same quarter last year, which indicates a []

Transcript Daily | November 29, 2021

Does NuCana plc (NASDAQ: NCNA) Still Look Attractive After A 5.58% Selloff Last Week?

During the last session, NuCana plc (NASDAQ:NCNA)s traded shares were 0.36 million, with the beta value of the company hitting 0.73. At the end of the trading day, the stocks price was $2.84, reflecting an intraday gain of 7.98% or $0.21. The 52-week high for the NCNA share is $7.83, that puts it down -175.7 Does NuCana plc (NASDAQ: NCNA) Still Look Attractive After A 5.58% Selloff Last Week? Read More »

Marketing Sentinel | November 25, 2021

Equities Analysts Issue Forecasts for NuCana plcs FY2024 Earnings (NASDAQ:NCNA)

NuCana plc (NASDAQ:NCNA) Investment analysts at Oppenheimer upped their FY2024 earnings per share (EPS) estimates for shares of NuCana in a report issued on Tuesday, November 23rd. Oppenheimer analyst L. Gershell now expects that the company will post earnings of $0.08 per share for the year, up from their prior estimate of $0.04. Several []

Dakota Financial News | November 25, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4609 seconds.